Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Clinical trial NCT02900560 · TERMINATED
Trial details
- NCT number
- NCT02900560
- Sponsor
- Translational Research in Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2021-05-27
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.